SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-09-003035
Filing Date
2009-04-23
Accepted
2009-04-23 06:00:48
Documents
6
Period of Report
2009-06-05
Effectiveness Date
2009-04-23

Document Format Files

Seq Description Document Type Size
1 RXI PHARMACEUTICALS CORPORATION b73679dfdef14a.htm DEF 14A 412156
2 GRAPHIC b73679dfb7367900.gif GRAPHIC 1250
3 GRAPHIC b73679dfb7367902.gif GRAPHIC 2348
4 GRAPHIC b73679dfb7367903.gif GRAPHIC 3253
5 GRAPHIC b73679dfb7367906.gif GRAPHIC 79937
6 GRAPHIC b73679dfb7367907.gif GRAPHIC 67785
  Complete submission text file 0000950135-09-003035.txt   627269
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 09765011
SIC: 2834 Pharmaceutical Preparations